Craft

Heska

Stock Price

$120

2023-06-13

Market Capitalization

$1.3 B

2023-06-13

Revenue

$257.3 M

FY, 2022

Heska Summary

Company Summary

Overview
Heska sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products. Its OVP segment includes private label vaccine and pharmaceutical production for cattle but also for other species, including equine, porcine, avian, feline and canine.
Type
Public
Status
Active
Founded
1952
HQ
Loveland, CO, US | view all locations
Website
https://www.heska.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Kevin Wilson, Chief Executive Officer & President

    • Catherine Grassman, Executive Vice President, Chief Financial Officer

      • Steven M. Eyl, Executive Vice President, Chief Commercial Officer and President, scil animal care company

        • Nancy Wisnewski, Chief Operating Officer

          LocationsView all

          7 locations detected

          • Loveland, CO HQ

            United States

            3760 Rocky Mountain Ave

          • Des Moines, IA

            United States

            Des Moines, IA, USA

          • Melbourne, VIC

            Australia

            68 Norcal Rd

          • Les Ulis, IDF

            France

            6 Avenue des Andes

          • Hong Kong, Kowloon

            Hong Kong

            Wing Hing Industrial Building 14 Hing Yip St

          • Palmerston North, Manawatu-Wanganui

            New Zealand

            86 Pitt St

          and 1 others

          Heska Financials

          Summary Financials

          Revenue (Q1, 2023)
          $62.4M
          Gross profit (Q1, 2023)
          $27.4M
          Net income (Q1, 2023)
          ($10.1M)
          Cash (Q1, 2023)
          $125.2M
          EBIT (Q1, 2023)
          ($10.4M)
          Enterprise value
          $1.2B

          Footer menu